FDA approves weight- loss drug, with a new name - Qsymia The U. S. Food and Drug Administration approved the new weight loss pill Qsymia on Tuesday, adding to a very skimpy arsenal of drugs Americans can take to battle severe obesity - - and adding a last- minute name change after two years of wrangling over whether to approve the drug. Janet Woodcock, director of the FDA. Qsymia combines phentermine, a stimulant, with the anti- seizure drug topiramate. Metabolic acidosis can also cause kidney stones and damage bones. The FDA approves drugs for certain uses in certain people, but once a drug is approved, a licensed doctor may prescribe it as he or she sees fit. The once- a- day pill will be available only through mail order so that doctors cannot dispense it from their offices. ![]() FDA approves a third new weight-loss pill. FDA has approved a new weight loss. All of the new drugs work by decreasing appetite and all have. FDA Approves Liraglutide (Saxenda) for Weight Loss. The FDA approved liraglutide for weight loss under a risk. FDA Approves Liraglutide (Saxenda) for Weight. FDA Approves New Weight-Loss Drug. The company also plans to educate doctors about the drug's risks, which include birth defects, and to carefully watch users for any signs of heart damage. Barbara Troupin said in a statement. Michael Lauer, a cardiologist at the National Institutes of Health who was on the panel of experts that advised the FDA about the drug. Lauer and one other panelist voted against approval, but 2. February. Ephedra, fen- phen, phenylpropanolamine, and sibutramine had to be withdrawn from the market because of cardiovascular toxicity. Rimonabant was approved for sale in Europe, but was never approved in the United States because of severe psychiatric side effects. Public Citizen, a consumer group, has been campaigning against the drug, too. Research shows the medication increases heart rate, and four patients on the diet pill had non- fatal heart attacks during the clinical trials, while none of those on the placebo had heart attacks. Sidney Wolfe said in a statement. Fen- phen combined fenfluramine and phentermine - - one of the two drugs in Qsymia - - but it damaged the heart in some cases and caused a condition in some patients called pulmonary hypertension, which causes fluid to build up in the chest, bringing a feeling of breathlessness. ![]() The two drugs together seem to lower appetite while keeping patients perky. Lauer said he would have liked to see more tests to specifically look for heart problems before the FDA approves the drug. ![]() ![]() About half lost 1. Related stories on Vitals. ![]() Food and Drug Administration approved the new weight loss pill Qsymia on Tuesday, adding to a very skimpy arsenal of drugs Americans can take to battle. Saxenda is the fourth drug for weight loss OK'd. It hasn't been compared directly with other recently approved weight loss drugs. FDA approves injectable drug Saxenda to help people with severe weight problems. FDA approves weight-management drug Contrave. Contrave is a combination of two FDA-approved drugs. FDA: Weight Loss Drugs; CDC. The New Obesity Drugs: an Rx for Weight Loss? ![]() The FDA Just Approved 'Stomach Draining' As Treatment for Obesity A new weight loss device offers a novel approach to cutting calories: draining them out of the. New Weight Loss Drug Approved By FDA: Compare Diet Pills, Diets, And Supplements.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |